NCT04954885View on ClinicalTrials.gov

Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

May 18, 2021

Primary Completion Date

October 12, 2022

Study Completion Date

October 12, 2022

Conditions
Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
Interventions
PROCEDURE

Biospecimen Collection

Undergo stool sample

OTHER

Physical Performance Testing

Undergo short physical performance battery

OTHER

Physical Performance Testing

Perform 6-minute walk test

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER